Related Experiment Videos

Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric

Ronald N Hines1, Dana Sargent, Herman Autrup

  • 1Medical College of Wisconsin, Department of Pediatrics, Children's Research Institute, Children's Hospital and Health Systems, Milwaukee, Wisconsin 53226-4801, USA.

Insights

This study explores methods for assessing risks in sensitive populations, focusing on pediatric risk assessment. It suggests these approaches can be adapted for other vulnerable groups, highlighting future research needs.

Area of Science:

  • Environmental Health Sciences
  • Toxicology
  • Risk Assessment Methodology

Background:

  • Assessing risk profiles of sensitive populations requires diverse methodological approaches.
  • A substantial body of literature exists for evaluating the pediatric population.
  • The Health and Environmental Sciences Institute (HESI) Subcommittee on Risk Assessment of Sensitive Populations reviewed existing methodologies.

Purpose of the Study:

  • To identify a spectrum of methodological approaches for risk assessment in sensitive populations.
  • To evaluate the applicability of pediatric risk assessment methodologies to other sensitive populations.
  • To provide recommendations for future research and alternative methodological considerations.

Main Methods:

  • Literature review of key references in pediatric risk assessment.
  • Analysis of methodological approaches for their potential extrapolation to other sensitive populations.
  • Expert evaluation by the HESI Subcommittee on Risk Assessment of Sensitive Populations.

Main Results:

  • A range of methodological approaches for risk assessment were identified from the pediatric literature.
  • The potential for adapting these methods to assess other sensitive populations was considered.
  • Gaps in current methodologies and areas for future research were highlighted.

Conclusions:

  • Methodologies developed for pediatric risk assessment can potentially be adapted for other sensitive populations.
  • Further research is needed to refine and validate these extrapolated approaches.
  • A comprehensive "tool chest" of methods is crucial for adequately characterizing sensitive populations.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...